Skip to content
LIVE MARKETS
--:--:--
ET
Testsite
Thoughts, stories and ideas.
40 filings/day — zero noise
Today's
stories · chronological wire
Search the wire
⌘K
Sign in
Subscribe
Home
INCY
INCY
1 story on the wire
INCY
1 filing
Chronological · ET
12:09
INCY
Incyte's Phase 3 Retifanlimab Anal Cancer Trial Listed as Completed
The POD1UM-303/InterAACT 2 study of retifanlimab added to carboplatin-paclitaxel in advanced anal cancer now carries COMPLETED status on ClinicalTrials.gov.
Clinical
Sep 2
10 days ago
PRO
No filings match.
Try another ticker or clear the filter.
LOAD EARLIER